Article
Myeloperoxidase polymorphism, menopausal status, and breast cancer risk: an update meta-analysis.
PloS one - 1 Jan 2013
Qin Xue, Deng Yan, Zeng Zhi-Yu, Peng Qi-Liu, Huang Xiu-Li, Mo Cui-Ju, Li Shan, Zhao Jin-Min
Abstract excerpt
Myeloperoxidase (MPO) is a metabolic/oxidative lysosomal enzyme secreted by reactive neutrophils at the sites of inflamed organs and tissues during phagocytosis. MPO has been either directly or indirectly linked to neoplasia, which is a well-established risk factor for many types of cancer. A large number of studies have reported the role of MPO G-463A polymorphism regarding breast-cancer risk. However, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
